On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


Kingman Minerals Ltd. (TSX.V: KGS) Increasing Gold Production as Price Edges Closer to Record Ten-Year High

  • Gold nearly hits ten-year high of $1921, last seen in 2011
  • Investors continue shifting capital to gold due to economic effects of COVID-, other geopolitical events
  • KGS increasing gold production by revitalizing historic gold mining sites, extracting remaining wealth with modern technology
  • KGS recently commissioned two gold exploration programs to be completed by Burgex Inc.

As central banks continue firing up the printing presses, investors are responding by diverting large amounts of capital into safe-haven assets like gold, driving the price closer to its 10-year record high of $1921 (http://ibn.fm/RnrCe). The upending of the global economy by geopolitical events like COVID-19 continues to drive the market towards precious metals like gold, along with increasing interest in mining companies like Kingman Minerals (TSX.V: KGS). With a strategic focus on the acquisition, exploration and development of gold and silver properties in North America, Canada-based KGS is positioned to benefit from the increased shift towards gold investment through new drilling campaigns aimed at increasing production.

The price of gold continues to rally amid inflation fears, geopolitical tensions and a weakening U.S. dollar, driving investors worldwide to shift assets into gold as a defensive measure. KGS is positioned to profit from these gold price rallies through its acquisition strategy that aims to revitalize historic mining sites and extract the remaining gold left behind through the use of cost-efficient modern technology unavailable to previous generations.

Among KGS’s portfolio is the Cadillac East Property, located approximately 55 kilometers east of Val d’Or, a key mining and exploration hub located in Quebec, Canada. Following numerous geophysical and geological surveys by private companies and the government of Quebec, KGS recently acquired an interest in the property from an arm’s length vendor with an option agreement to earn 100% over three years. Consisting of 12 claims, the area includes multiple potential targets for future exploration along with additional exploration work done in 2017 that identified potential value in other metals that include silver, copper, zinc and nickel.

Another key KGS property is the Mohave Project, located in the Music Mountains region of Mohave County, Arizona. Comprising 20 lode claims, the property also includes the historic 167-hectare Rosebud Mine that was originally discovered during the famous “Gold Rush” era of the 1880s. While most of the easily-extracted gold has already been accessed using traditional manual techniques, some wealth remains, according to studies conducted in the 1980s by L.A. Bayrock Ph.D. P.Geo. on behalf of Stellar Resource Corporation (http://ibn.fm/m6Bb5).

KGS recently commissioned two gold exploration programs to be completed by Burgex Inc. (http://ibn.fm/KFKX7), a consulting services company that specializes in the analysis of abandoned mining sites throughout the western United States.

Previously known as Astorius Resources Ltd., KGS is engaged in the acquisition, exploration and development of historic mining properties in North America. Based in the British Columbia province of Canada, KGS provides significant shareholder value through its strategy of developing a diverse portfolio of high-production, low-cost, lifelong assets.

For more information, visit the company’s website at www.KingmanMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

September 25, 2020

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced a statistically significant improvement in clinical benefit. In preclinical studies, the company’s second drug candidate, […]

Rotate your device 90° to view site.